Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Piperazines as inhibitors of MMPs and/or TNF-alpha prepared at Fujisawa

Oct. 1, 1998

NPS Pharmaceuticals initiates clinical trials for NPS-1776

Oct. 1, 1998

New arthritis Rx now available in Japan

Sep. 30, 1998

Selectin inhibitors under study at Kanebo

Sep. 28, 1998

TheraTech receives NIH funding for novel approach to rheumatoid arthritis

Sep. 24, 1998

Mitsui Chemicals prepares cell adhesion inhibitors

Sep. 24, 1998

PAF antagonist evaluated in patients with rheumatoid arthritis; results disappointing

Sep. 22, 1998

Novel antiinflammatory azulenes disclosed by Kotobuki

Sep. 21, 1998

Selective and sensitive p38 MAP kinase inhibitor identified by SmithKline Beecham

Sep. 18, 1998

La Jolla identifies target of antibodies responsible for life-threatening autoimmune disorder

Sep. 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...